SynBioBeta Speaker
Ivana Aguiar
NanoProX
COO
I am co-founder of NanoProx, a startup developing bismuth-based nanoparticles to improve radiotherapy in oncology. My work focuses on bridging nanotechnology and cancer treatment, with the goal of developing more effective and precise therapeutic approaches.My scientific background is in the synthesis of bismuth-based nanomaterials, and I have been especially interested in how these materials can be engineered for biomedical applications with real translational potential. Over time, this interest evolved from fundamental materials research into a broader commitment to developing technologies that can address unmet needs in cancer care.At NanoProx, I work at the intersection of nanotechnology, oncology, and innovation. What motivates me most is the possibility of turning advances in materials science into practical tools that can strengthen radiotherapy and ultimately improve patient outcomes. I am particularly passionate about building solutions that combine strong scientific foundations with a clear clinical purpose.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Ivana
This Year
Session lineup still growing
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Featuring
Speaker Coming Soon
